Five phage anti-Staphylococcus aureus bacteriophage cocktail (Qeen BioTechnologies)

N/A

Report date: 2026/03/31 20:00:21

Base Information

Drug NameFive phage anti-Staphylococcus aureus bacteriophage cocktail (Qeen BioTechnologies)
Drug Alias NameN/A
ClassificationBiologics > Bacteriophages
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsProsthesis-Related Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesQeen BioTechnologies
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsProsthesis-Related Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A